Product information and disease descriptionProduct descriptionProduct information
Indication
1 evidence topic · 1 source
Tirabrutinib
Primary central nervous system lymphoma
- Manufacturer
- Deciphera Pharmaceuticals
- Regulatory submission
- NDA submitted December 2025
- Last updated